A Prospective Observational Study Evaluating Relevance of Measurement Instruments in Assessing Effectiveness of ACARIZAX in the Treatment of Moderate to Severe House Dust Mite Allergic Rhinitis With/Without Allergic Asthma in Chinese
Latest Information Update: 22 Mar 2024
At a glance
- Drugs House dust mite allergy immunotherapy-ALK Abello (Primary)
- Indications Allergic asthma; Allergic rhinitis
- Focus Therapeutic Use
- Sponsors ALK-Abello
Most Recent Events
- 30 Jan 2024 Status changed from not yet recruiting to recruiting.
- 04 Dec 2023 New trial record